Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Beclabuvir

Generic Name: Beclabuvir

Drug Type: Small Molecule

Chemical Formula: C_₃₆H_₄₅N_₅O_₅S

CAS Number: 958002-33-0

Unique Ingredient Identifier: MYW1X5CO9S

Overview

Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

Background

Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of Drug Combination on Pharmacokinetics in Healthy Volunteers

Phase 1

Completed

Posted: 2014/06/26

Sponsor:Bristol-Myers Squibb

ID:NCT02175602

Absolute Bioavailability of BMS-791325

Phase 1

Completed

Posted: 2014/04/11

Sponsor:Bristol-Myers Squibb

ID:NCT02112110

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Phase 1

Completed

Posted: 2014/04/09

Sponsor:Bristol-Myers Squibb

ID:NCT02108639

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

Phase 1

Completed

Posted: 2014/04/04

Sponsor:Bristol-Myers Squibb

ID:NCT02103569

Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin

Phase 1

Completed

Posted: 2014/04/04

Sponsor:Bristol-Myers Squibb

ID:NCT02104843

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy